Search

Your search keyword '"Günther Weindl"' showing total 73 results

Search Constraints

Start Over You searched for: Author "Günther Weindl" Remove constraint Author: "Günther Weindl"
73 results on '"Günther Weindl"'

Search Results

1. Label-free biosensor assay decodes the dynamics of Toll-like receptor signaling

2. P2X7 receptor activation leads to NLRP3-independent IL-1β release by human macrophages

3. Toxicological and Safety Pharmacological Profiling of the Anti-Infective and Anti-Inflammatory Peptide Pep19-2.5

4. Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5

5. Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds

6. Regulation of Dendritic Cell Function in Inflammation

7. Glycosylation of Candida albicans cell wall proteins is critical for induction of innate immune responses and apoptosis of epithelial cells.

8. An update on endotoxin neutralization strategies in Gram-negative bacterial infections

9. Biological Characterization, Mechanistic Investigation and Structure‐Activity Relationships of Chemically Stable TLR2 Antagonists

10. Lysosomotropic beta blockers induce oxidative stress and IL23A production in Langerhans cells

11. Intracellular Lipopolysaccharide Sensing as a Potential Therapeutic Target for Sepsis

12. Further hit optimization of 6-(trifluoromethyl)pyrimidin-2-amine based TLR8 modulators: Synthesis, biological evaluation and structure-activity relationships

13. Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5

14. Immunocompetent Human Intestinal Models in Preclinical Drug Development

15. Immunocompetent Human Intestinal Models in Preclinical Drug Development

16. Antimicrobial endotoxin-neutralizing peptides promote keratinocyte migrationviaP2X7 receptor activation and accelerate wound healingin vivo

17. Characterization of reconstructed human skin containing Langerhans cells to monitor molecular events in skin sensitization

18. Identification and validation of a novel dual small-molecule TLR2/8 antagonist

19. TatS: a novel in vitro tattooed human skin model for improved pigment toxicology research

20. The novel small-molecule antagonist MMG-11 preferentially inhibits TLR2/1 signaling

21. Synthetic Anti-lipopolysaccharide Peptides (SALPs) as Effective Inhibitors of Pathogen-Associated Molecular Patterns (PAMPs)

22. Identification and characterization of a novel chemotype for human TLR8 inhibitors

23. Recognition of Propionibacterium acnes by human TLR2 heterodimers

24. Lysosomotropic drugs enhance pro-inflammatory responses to IL-1β in macrophages by inhibiting internalization of the IL-1 receptor

25. Development of Antimicrobial Peptides Based on Limulus Anti-Lipopolysaccharide Factor (LALF)

26. LPS-neutralizing peptides reduce outer membrane vesicle-induced inflammatory responses

27. Identification of a pyrogallol derivative as a potent and selective human TLR2 antagonist by structure-based virtual screening

28. Antimicrobial endotoxin-neutralizing peptides promote keratinocyte migration via P2X7 receptor activation and accelerate wound healing in vivo

29. Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cellsin vitro

30. Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses

31. Chloroquine Promotes IL-17 Production by CD4+ T Cells via p38-Dependent IL-23 Release by Monocyte-Derived Langerhans-like Cells

32. Core-multishell nanotransporters enhance skin penetration of the cell-penetrating peptide low molecular weight protamine

33. Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin

34. TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts

35. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

36. Biotransformation of 2,4-toluenediamine in human skin and reconstructed tissues

37. Cell type-specific regulatory effects of glucocorticoids on cutaneous TLR2 expression and signalling

38. Synthetic antimicrobial and LPS-neutralising peptides suppress inflammatory and immune responses in skin cells and promote keratinocyte migration

39. Host Defence Against Candida albicans and the Role of Pattern-recognition Receptors

40. Increased cutaneous absorption reflects impaired barrier function of reconstructed skin models mimicking keratinisation disorders

41. The Candida albicans cell wall protein Rhd3/Pga29 is abundant in the yeast form and contributes to virulence

42. Epithelial Cells and Innate Antifungal Defense

43. Charakterisierung der Interaktion zwischen Candida albicans und Wirtszellen

44. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis

45. Erratum

46. The Early Transcriptional Response of Human Granulocytes to Infection withCandida albicansIs Not Essential for Killing but Reflects Cellular Communications

47. Acute myeloid leukaemia-derived Langerhans-like cells enhance Th1 polarization upon TLR2 engagement

48. Sphingosine 1-phospate differentially modulates maturation and function of human Langerhans-like cells

49. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety

50. Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia

Catalog

Books, media, physical & digital resources